Hillsdale Investment Management »

Prelude Therapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $434k 81k 5.33

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Enerflex (EFXT)
Suncor Energy (SU)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Agnico (AEM)
Cenovus Energy (CVE)
NVIDIA Corporation (NVDA)
Shopify Inc cl a (SHOP)
Apple (AAPL)
Barrick Mining Corp (B)

View all positions for Hillsdale Investment Management

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics